AccScience Publishing / CAR / Online First / DOI: 10.36922/CAR026270005
Cite this article
48
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Exploratory functional, histological, and biochemical outcomes following OctaAge administration in naturally aged female Diannan small-ear pigs

Lei Wang1,2† ,  Xiangfeng Yang1,3† ,  Guoqiang Li4† ,  Yixiao Chen1,3 ,  Yu Yang1,3 ,  Hong Xue1,3 ,  Yingying Xiang5 ,  Can Hu5 ,  Can Hu5 ,  Guoqiang Zhu1,3 ,  Guoqing Yin1,3 ,  Haiyang Hu1,3 ,  Qin Fu2 ,  Ming Li4 ,  Zhang Li4 ,  Lei Jin4 ,  Chen Li2 ,  Qinwei Tang2 ,  Zhiyuan Zhang2 ,  Gang Wang6 ,  Zhenxing Wang1,3 ,  Xiaobo Liao2 ,  Yulong Yin4* ,  Mei Liu4* ,  Hui Xie1,3*
Show Less
1 Department of Orthopedics, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan , China
2 Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan , China
3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan , China
4 College of Animal Science and Technology, Hunan Agricultural University, Changsha, Hunan , China
5 Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan , China
6 Zhuhai Hengqin ONA Regenerative Medicine Co., Ltd., Zhuhai, Guangdong , China
†These authors contributed equally to this work.
Received: 29 June 2026 | Revised: 10 September 2026 | Accepted: 24 September 2026 | Published online: 8 October 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Anti-aging interventions increasingly aim to modify more than one biological process, yet most candidates are still tested first in short-lived models, leaving limited information from naturally aged large animals. We evaluated OctaAge (an eight-component anti-aging formulation containing L-theanine, calcium alpha-ketoglutarate, resveratrol, quercetin, fisetin, apigenin, magnesium bisglycinate, and spermidine) in 11 female Diannan small-ear pigs aged 7–8 years. After a one-month acclimation period, pigs were allocated, without a random sequence and using age and body weight for balance, to a concurrent feed-control group or three months of OctaAge administration. Cardiac function and body weight were monitored longitudinally; endpoint analyses included behavioral changes, organ coefficients, femoral quantitative ultrasound measurements, intervertebral disc morphology, serum chemistry, and histological findings. OctaAge-treated pigs showed higher ejection fraction and fractional shortening, greater open-field exploration, and a higher T-maze correct-choice rate than the control group. Histological analyses showed lower cardiac collagen content and cardiomyocyte cross-sectional area, lower liver and kidney collagen content, higher hippocampal Nissl-positive area, and larger skeletal-muscle fiber cross-sectional area in OctaAge-treated pigs. Femoral quantitative ultrasound measurements were also higher in OctaAge-treated pigs, whereas body-weight trajectories were similar between groups. Renal chemistry, glucose, and lipid measures did not change significantly. OctaAge administration was therefore associated with differences in selected aging-related functional and histological parameters in this naturally aged pig cohort. Given the non-randomized design, small sample size, and multiple exploratory endpoints, the findings require confirmation in a prespecified, adequately powered study.

Keywords
Natural aging
Large-animal model
Multi-compound formulation
Translational geroscience
Anti-aging intervention
Funding
This study was supported by the Health Research Project of Hunan Provincial Health Commission (grant number 20258058) and Hunan Provincial Science and Technology Innovation Program (grant number 2024DK2004).
Conflict of interest
Prof. Hui Xie serves as the Editor-in-Chief of this journal, but was not in any way involved in the editorial and peer-review process conducted for this paper, directly or indirectly. The authors have filed a patent application related to the OctaAge anti-aging multi-compound formulation (application no. 2026113300469); the application is pending and has not been granted at the time of manuscript preparation. Gang Wang is affiliated with Zhuhai Hengqin ONA Regenerative Medicine Co., Ltd., which supplied the formulation used in this study. The relationship between the authors and LifeSpanPlus LLC was limited to scientific collaboration; no author had an employment, consulting, advisory, equity, funding, or other financial relationship with LifeSpanPlus LLC in connection with this study. OctaAge was the research designation used for the LifeSpanPlus LLC ReVitalizer product and was not a distinct commercial formulation. The authors declare no other competing interests.
References
  1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153(6):1194-1217. doi: 10.1016/j.cell.2013.05.039
  2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. doi: 10.1016/j.cell.2022.11.001
  3. Kroemer G, Maier AB, Cuervo AM, et al. From geroscience to precision geromedicine: Understanding and managing aging. Cell. 2025;188(8):2043-2062. doi: 10.1016/j.cell.2025.03.011
  4. Kennedy BK, Berger SL, Brunet A, et al. Geroscience: Linking Aging to Chronic Disease. Cell. 2014;159(4):709-713. doi: 10.1016/j.cell.2014.10.039
  5. Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183-192. doi: 10.1038/s41586-019-1365-2
  6. Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018;561(7721):45-56. doi: 10.1038/s41586-018-0457-8
  7. Colman RJ, Anderson RM, Johnson SC, et al. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys. Science. 2009;325(5937):201-204. doi: 10.1126/science.1173635
  8. Mattison JA, Colman RJ, Beasley TM, et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017;8(1):14063.doi: 10.1038/ncomms14063
  9. Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS. Swine as Models in Biomedical Research and Toxicology Testing. Vet Pathol. 2011;49(2):344-356. doi: 10.1177/0300985811402846
  10. Crick SJ, Sheppard MN, Ho SY, Gebstein L, Anderson RH. Anatomy of the pig heart: comparisons with normal human cardiac structure. Journal of Anatomy. 1998;193(1):105-119. doi: 10.1046/j.1469-7580.1998.19310105.x
  11. Perleberg C, Kind A, Schnieke A. Genetically engineered pigs as models for human disease. Dis Model Mech. 2018;11(1):dmm030783.doi: 10.1242/dmm.030783
  12. Fanjul V, Jorge I, Camafeita E, et al. Identification of common cardiometabolic alterations and deregulated pathways in mouse and pig models of aging. Aging Cell. 2020;19(9):e13203.doi: 10.1111/acel.13203
  13. Chin RM, Fu X, Pai MY, et al. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510(7505):397-401. doi: 10.1038/nature13264
  14. Asadi Shahmirzadi A, Edgar D, Liao CY, et al. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice. Cell Metabolism. 2020;32(3):447-456.e6. doi: 10.1016/j.cmet.2020.08.004
  15. Eisenberg T, Abdellatif M, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428-1438. doi: 10.1038/nm.4222
  16. Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science. 2018;359(6374):eaan2788.doi: 10.1126/science.aan2788
  17. Kiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. The American Journal of Clinical Nutrition. 2018;108(2):371-380. doi: 10.1093/ajcn/nqy102
  18. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342. doi: 10.1038/nature05354
  19. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span. Cell Metabolism. 2008;8(2):157-168. doi: 10.1016/j.cmet.2008.06.011
  20. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644-658. doi: 10.1111/acel.12344
  21. Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):1246-1256. doi: 10.1038/s41591-018-0092-9
  22. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. doi: 10.1016/j.ebiom.2018.09.015
  23. Perrott KM, Wiley CD, Desprez PY, Campisi J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. GeroScience. 2017;39(2):161-173. doi: 10.1007/s11357-017-9970-1
  24. Salehi B, Venditti A, Sharifi-Rad M, et al. The Therapeutic Potential of Apigenin. IJMS. 2019;20(6):1305. doi: 10.3390/ijms20061305
  25. Baba Y, Inagaki S, Nakagawa S, Kaneko T, Kobayashi M, Takihara T. Effects of L-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study. Journal of Medicinal Food. 2021;24(4):333-341. doi: 10.1089/jmf.2020.4803
  26. Hidese S, Ogawa S, Ota M, et al. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019;11(10):2362. doi: 10.3390/nu11102362
  27. Barbagallo M, Veronese N, Domínguez LJ. Magnesium in Aging, Health and Diseases. Nutrients. 2021;13(2):463. doi: 10.3390/nu13020463
  28. Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi: 10.1371/journal.pbio.3000410
  29. Ekser B, Gridelli B, Cooper DKC. Porcine alanine transaminase after liver allo‐and xenotransplantation. Xenotransplantation. 2012;19(1):52-55. doi: 10.1111/j.1399-3089.2011.00686.x
  30. Frangogiannis NG. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Molecular Aspects of Medicine. 2019;65:70-99. doi: 10.1016/j.mam.2018.07.001
  31. Steenman M, Lande G. Cardiac aging and heart disease in humans. Biophys Rev. 2017;9(2):131-137. doi: 10.1007/s12551-017-0255-9
  32. Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18(6):400-423. doi: 10.1038/s41569-020-00480-6
  33. Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539(7628):180-186. doi: 10.1038/nature20411
  34. Sato Y, Yanagita M. Immunology of the ageing kidney. Nat Rev Nephrol. 2019;15(10):625-640. doi: 10.1038/s41581-019-0185-9
  35. Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol. 2022;18(9):545-557. doi: 10.1038/s41581-022-00590-z
  36. Maeso-Díaz R, Ortega-Ribera M, Lafoz E, et al. Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease. Aging and disease. 2019;10(4):684. doi: 10.14336/ad.2019.0127
  37. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21(4):543-59.doi: 10.1007/s00198-009-1059-y
  38. Reid IR. A broader strategy for osteoporosis interventions. Nat Rev Endocrinol. 2020;16(6):333-339. doi: 10.1038/s41574-020-0339-7
Share
Back to top
Cell Aging & Regeneration, Published by AccScience Publishing